Ken Griffin Laboratory Corp Of America Holdings Call Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$209.01 - $232.56 $6.12 Million - $6.81 Million	-29,300 Reduced 42.96%	38,900 $8.5 Million
Q4 2023 Feb 14, 2024	SELL	$197.69 - $227.29 $27.6 Million - $31.7 Million	-139,600 Reduced 67.18%	68,200 $15.5 Million
Q3 2023 Nov 14, 2023	SELL	$201.05 - $221.7 $3.48 Million - $3.84 Million	-17,300 Reduced 7.69%	207,800 $41.8 Million
Q2 2023 Aug 14, 2023	SELL	$211.93 - $241.33 $7.5 Million - $8.54 Million	-35,400 Reduced 13.59%	225,100 $54.3 Million
Q1 2023 May 15, 2023	SELL	$213.32 - $257.83 $22.2 Million - $26.8 Million	-104,100 Reduced 28.55%	260,500 $59.8 Million
Q4 2022 Feb 14, 2023	BUY	$203.72 - $248.97 $51.6 Million - $63.1 Million	253,300 Added 227.58%	364,600 $85.8 Million
Q3 2022 Nov 14, 2022	BUY	$204.81 - $262.19 $9.5 Million - $12.2 Million	46,400 Added 71.49%	111,300 $22.8 Million

1.97M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.3B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.